European Commission approves Moderna vaccine

After Moderna recently said it would increase its global supply of its Covid-19 vaccine, today, the EU’s executive commission—formally known as the European Commission—has officially granted conditional market authorization (CMA) for the vaccine. The news comes after the European Medicines Agency (EMA) recommended its authorization earlier in the day.

From a distribution standpoint, this greenlights the move of 160 million doses that are expected to be delivered to the EU between Q1 and Q3.

Pfizer and BioNTech SE, whose vaccine had previously been granted CMA in December, reached a deal to supply the EU with an additional 100 million doses this year, bringing the total to 300 million. And yesterday, Bloomberg reported that there are now talks to acquire up to 300 million additional doses, though nothing has been finalized yet.